These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11480459)

  • 1. Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells.
    Sakata N; Meng J; Takebayashi S
    J Atheroscler Thromb; 2000; 7(3):169-76. PubMed ID: 11480459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells.
    Higashi T; Sano H; Saishoji T; Ikeda K; Jinnouchi Y; Kanzaki T; Morisaki N; Rauvala H; Shichiri M; Horiuchi S
    Diabetes; 1997 Mar; 46(3):463-72. PubMed ID: 9032104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
    Pugliese G; Pricci F; Romeo G; Pugliese F; Mené P; Giannini S; Cresci B; Galli G; Rotella CM; Vlassara H; Di Mario U
    Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 is suppressed by a protease in the tubule cell line LLC-PK1.
    Xiang G; Schinzel R; Simm A; Münch G; Sebekova K; Kasper M; Niwa T; Schmitz C; Heidland A
    Nephrol Dial Transplant; 2001 Aug; 16(8):1562-9. PubMed ID: 11477156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of altered RGD sequence in reduced adhesive and spreading activities of advanced glycation end product-modified fibronectin to vascular smooth muscle cells.
    Sakata N; Sasatomi Y; Meng J; Ando S; Uesugi N; Takebayashi S; Nagai R; Horiuchi S
    Connect Tissue Res; 2000; 41(3):213-28. PubMed ID: 11264870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative damage of vascular smooth muscle cells by the glycated protein-cupric ion system.
    Sakata N; Miyamoto K; Meng J; Tachikawa Y; Imanaga Y; Takebayashi S; Furukawa T
    Atherosclerosis; 1998 Feb; 136(2):263-74. PubMed ID: 9543097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type V collagen represses the attachment, spread, and growth of porcine vascular smooth muscle cells in vitro.
    Sakata N; Jimi S; Takebayashi S; Marques MA
    Exp Mol Pathol; 1992 Feb; 56(1):20-36. PubMed ID: 1547866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression.
    Pugliese G; Pricci F; Leto G; Amadio L; Iacobini C; Romeo G; Lenti L; Sale P; Gradini R; Liu FT; Di Mario U
    Diabetes; 2000 Jul; 49(7):1249-57. PubMed ID: 10909985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in the stimulatory effect of advanced glycation end products on growth of rat aortic smooth muscle cells.
    Seki N; Hashimoto N; Sano H; Horiuchi S; Yagui K; Makino H; Saito Y
    Metabolism; 2003 Dec; 52(12):1558-63. PubMed ID: 14669155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis. A relationship to transforming growth factor-beta 1.
    Sakuda H; Nakashima Y; Kuriyama S; Sueishi K
    Am J Pathol; 1992 Dec; 141(6):1507-16. PubMed ID: 1281623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the polyol pathway and non-enzymatic glycation on aortic smooth muscle cell migration and monocyte adhesion.
    Dan Q; Wong R; Chung SK; Chung SS; Lam KS
    Life Sci; 2004 Dec; 76(4):445-59. PubMed ID: 15530506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mitogen-activated protein kinase and protein kinase C in fibronectin production in human vascular smooth muscle cells.
    Kaiura TL; Itoh H; Kent KC
    J Surg Res; 1999 Jun; 84(2):212-7. PubMed ID: 10357922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDGF-like growth factor from SV40-transformed smooth muscle cells promotes growth in an autocrine or paracrine manner.
    Sakata N; Fujimitsu K; Jimi S; Takebayashi S
    Exp Mol Pathol; 1994 Feb; 60(1):39-51. PubMed ID: 8162969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of growth factors, cytokines, and extracellular matrix proteins on fibronectin production in human vascular smooth muscle cells.
    Kaiura TL; Itoh H; Kubaska SM; McCaffrey TA; Liu B; Kent KC
    J Vasc Surg; 2000 Mar; 31(3):577-84. PubMed ID: 10709072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta regulates increased ductus arteriosus endothelial glycosaminoglycan synthesis and a post-transcriptional mechanism controls increased smooth muscle fibronectin, features associated with intimal proliferation.
    Boudreau N; Clausell N; Boyle J; Rabinovitch M
    Lab Invest; 1992 Sep; 67(3):350-9. PubMed ID: 1405493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta.
    Kim YS; Kim BC; Song CY; Hong HK; Moon KC; Lee HS
    J Lab Clin Med; 2001 Jul; 138(1):59-68. PubMed ID: 11433229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta 1 stimulates type V collagen expression in bovine vascular smooth muscle cells.
    Lawrence R; Hartmann DJ; Sonenshein GE
    J Biol Chem; 1994 Apr; 269(13):9603-9. PubMed ID: 8144547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of protein kinase C and its alpha subtype on human vascular smooth muscle cell proliferation, migration and fibronectin production.
    Okazaki J; Mawatari K; Liu B; Kent KC
    Surgery; 2000 Aug; 128(2):192-7. PubMed ID: 10922991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemistry of intermediate filaments in cultured arterial smooth muscle cells: differences in desmin and vimentin expression related to cell of origin and/or plating time.
    Sakata N; Kawamura K; Fujimitsu K; Chiang YY; Takebayashi S
    Exp Mol Pathol; 1990 Oct; 53(2):126-39. PubMed ID: 2261944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta receptor and fibronectin expressions in aortic smooth muscle cells in diabetic rats.
    Kanzaki T; Shiina R; Saito Y; Zardi L; Morisaki N
    Diabetologia; 1997 Apr; 40(4):383-91. PubMed ID: 9112014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.